CD163 and myeloid sarcoma: Conversely, both DMT1 and the hemoglobin-haptoglobin complex receptor CD163 were significantly upregulated on a subtype of MCs at MS lesion rims and also strongly correlated with iron-positive MCs across ROIs of cases containing chronic active lesions.